PILOT PROJECT GRANTS: American Cancer Society IRG Awards
- Pilot funding for CANCER-RELATED research in basic, clinical, prevention & control, behavioral, health services and epidemiology.
- Up to $30,000 award.
- Applications accepted for general cancer-related projects and for special interest projects in adolescent-and-young-adult cancer research.
IRG pilot project grants are intended to support independent, self-directed investigators early in their careers (usually assistant professor or equivalent). Applicants for the pilot project grants should be within 6 years of their first independent research or faculty appointment and eligible to apply for an independent national competitive research grant, but do not currently hold such a cancer-related grant.
Recipients of IRG pilot project grants must be, at the time of the application, citizens or noncitizen nationals of the United States or its possessions and territories, or must have been lawfully admitted to the United States for permanent residence at the time of application.
- Case CCC Pilot Application Cover Page Template [View PDF: Case CCC-pilot-app-cover-template]
- Case CCC Pilot Application LOI Template [View PDF: ACS-RFA-Spring-2018-LOI]
- Instructions [View PDF: ACS-RFA-Spring-2018-instructions
- Application Form [View Form: ACS-RFA-Spring-2018-application-form]
- Frequently Asked Questions [View PDF: ACS-RFA-Spring-2018-FAQs]
John Pounardjian, MBA, Cancer Center Administration, 216.844.8326, firstname.lastname@example.org
Request for Proposals for Case CCC Funding for Early Phase Clinical Trials
Request for Applications: Opportunities for Pilot Projects from VeloSano Bike to Cure
With the generous support from VeloSano Bike to Cure 2017, the Case Comprehensive Cancer Center is providing seed funding for highly innovative and impactful proposals that will generate key data for larger, nationally competitive grants. Projects aligned with at least one of six new Research Initiatives (Cancer Genomics, Cancer Immunotherapy, Brain Tumors, Drug Discovery and Development, Women’s Cancers, Community Outreach and Cancer Health Disparities) and the Center's Strategic Plan are preferred. Collaborative, multi-investigator projects are particularly encouraged.
Eligibility for funds will be restricted to PIs whose lab participated in VeloSano Bike to Cure 2017 (PI or lab members were riders, virtual riders, or volunteers). In addition, the lead PI of the application must not be eligible for CCF VeloSano funding. Co-PIs and Co-investigators are not required to have been VeloSano participants. All awardees (PI/Co-PI) are expected to participate in VeloSano 2018 and must present their research progress when requested by the Case Comprehensive Cancer Center.
- Up to 7 research projects will be funded. Total funds committed to this RFA are $500,000.
- Each research project can request a budget of up to $70,000 for one year.
- Research projects should be completed within one year.
- Strong investigative teams of Case Comprehensive Cancer Center members.
- Alignment with one or more Scientific Initiatives and the Cancer Center Strategic Plan is preferred.
- Highly innovative and impactful projects.
- All materials to complete the project should be in-hand or readily available. For example, tissue-based research will require an approved IRB protocol and patient cohort studies must have already recruited the cohort. Collection of new patient cohorts as the primary focus of the work is not responsive to this RFA.
- Projects must have a high likelihood of subsequent national-level funding.
- While investigators can be collaborators on multiple applications, only one application will be accepted per lead PI.
- All funds for core facilities must use Case Comprehensive Cancer Center cores, when available, rather than cores at institutions outside Cleveland unless a specific justification for use of another core is submitted and approved.
- VeloSano participation (and eligibility for this RFA) can be confirmed by contacting Case CCC pilots below.
View detailed instructions: [VeloSano-Instructions-2018]
Contact email@example.com or John Pounardjian at 216.844.8326 with any questions.
Limited Submission: V Foundation for Cancer Research 2018 V Scholar Award
The Case Comprehensive Cancer Center is invited to submit ONE nominee for consideration for the V Scholar Award Award.
As in 2017, the V Foundation is continuing to raise funds to support the Stuart Scott Memorial Cancer Research Fund. While not required, we encourage applications from young investigators from a minority ethnic group who is underrepresented in science. For the purposes of this application: African American or of African descent, Hispanic American (non-European) or Native American and/or an Alaskan Native would be included in minority groups. Among our highly ranked finalists for the 2018 V Scholar Award, we will designate at least one of the highest ranked applications from a minority applicant as the recipient of a 2018 Stuart Scott Memorial Fund V Scholar Award. Special focus area: ANY area of cancer research is eligible.
PURPOSE OF AWARD
The V Scholar Award supports young tenure-track faculty early in their cancer research career by funding projects that are either laboratory-based fundamental research or translational research. The total amount of the grant is $200,000 awarded in two annual installments of $100,000 each. Only direct costs of the research are supported by this award.
- Only research institutions that received this invitation may submit a nominee for consideration. Other affiliates of the institution that did not receive the email are not eligible to nominate an applicant.
- Institutions must be non-profit research institutions in the US or Canada.
Applicant Eligibility: All nominated applicants must meet all of the following criteria to be eligible to submit an
- Applicant must by nominated by their Cancer Center Director or other senior research official who is responsible for the internal nominee selection process may make the nomination. The nominator must certify that their nominee meets all eligibility criteria.
- Applicant must be employed at a non-profit research institution (e.g., 501c3, Section 170).
- Applicant must have at least 2 years post-doctoral (MD or PhD) fellowship training. For MDs, a minimum of one year is acceptable if only one year is required for the specialty.
- By the Due Date of the Application, applicants meet the following criteria:
- Hold a tenure-track faculty position as an assistant professor at their cancer research institution. Non-promotable, adjunct, affiliated, temporary, part-time or acting faculty positions are not eligible for this grant competition.
- Have been appointed to their first full-time assistant professor position within the last 5 years, and have not yet been promoted to Associate Professor.
- Clinical scientists may be eligible if the research institution can demonstrate that it will fully support the research applicant (e.g., dedicated lab space, start-up funds, dedicated research time).
- Applicants must be either US Citizens or be a permanent legal resident in the US.
- Applicant can NOT already hold an R01 or R01-equivalent grants.
- As of the Due Date of the Application, applicants who have been awarded RO1s or RO1 equivalent grants (Project leader on an NIH multi-investigator grant, ACS) as principal investigators or as co-leader at the time of application submission are not eligible for consideration as a V Scholar. In addition, applicants cannot be a co-leader on a SPORE project or (co)PI of the following NIH grant mechanisms: U01, DP1, DP2, R37, R23. In addition, principal investigators for research project grants (RPGs), analogous to NIH/NCI R01 awards, would be ineligible. The V Scholar award is meant to support research to leverage these larger awards so the nominee may not already have received these awards.
To be considered for the nomination, submit a one-page LOI and biosketch to firstname.lastname@example.org by March 10, 2018.
Limited Submission: 2018 V Foundation Translational Cancer Research Grant
The Case Comprehensive Cancer Center is invited to submit ONE nominee for consideration for the 2018 V Foundation Translational Cancer Research Grant.
PURPOSE OF AWARD
The V Foundation for Cancer Research seeks to support translational research projects within the scope of all types of cancers. The Translational Research Award is a $600,000 grant awarded in three annual installments of $200,000. Indirect costs up to a maximum of 10% within the total award are permitted.
Definition of a translational research project: Translational projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than 3 years. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial.
- Only research institutions that received this invitation may nominate an applicant. Other affiliates of the institution that did not receive the email are not eligible to nominate an applicant
- Institutions must be non-profit research institutions in the US or Canada.
Applicant Eligibility: Your nominated applicant must be the lead Principal Investigator (PI) on the Translational Award research team. The applicant must meet all of the following criteria to be eligible to submit an application:
- The nominee must be nominated by their Cancer Center Director if the research institution is a cancer center. If the research institution is not a cancer center, then the provost, dean or other senior research administrative official who is responsible for the internal nominee selection process may make the nomination. We do not review unsolicited applications.
- Applicant must be employed at a non-profit research institution (e.g. 501c3, Section 170).
- By the Due Date of the Application, the applicant who will lead the research team must have all the following:
- Be a scientist in a tenure-track faculty position at their cancer research institution. Non-promotable, adjunct, affiliated, temporary, part-time or acting faculty positions are not eligible for Principal Investigator nomination to lead the Translational Research Team.
- Applicants must be either a US or Canadian Citizen, or have a legal permit to work in the USA (either temporary or permanent).
To be considered for the nomination, submit a one-page LOI and biosketch to email@example.com by March 24, 2018.